Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies

NCT04164199 is registered in ClinicalTrials.gov with BeOne Medicines as lead sponsor.

NCT NCT04164199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04164199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies
Lead sponsor
BeOne Medicines
Phase
Phase 3
Overall status
Completed
Start date
December 19, 2019
Completion date
May 23, 2026
Enrollment
404 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancies